Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E2FN | ISIN: NO0013107490 | Ticker-Symbol: I8X0
Frankfurt
22.01.25
08:09 Uhr
0,007 Euro
0,000
0,00 %
Branche
IT-Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
IDEX BIOMETRICS ASA Chart 1 Jahr
5-Tage-Chart
IDEX BIOMETRICS ASA 5-Tage-Chart
GlobeNewswire (Europe)
273 Leser
Artikel bewerten:
(1)

IDEX BIOMETRICS ASA: IDEX Biometrics brings biometric smart cards to market with Cellfie Global

Finanznachrichten News

Oslo, Norway, and Seoul, South Korea 19 November 2024 - IDEX Biometrics has entered into a commercial development agreement with South Korean smart card manufacturer Cellfie Global (formerly ICK) to design, manufacture and market biometric metal and PVC cards for bank and fintech launches in USA, Europe and Asia. This gives IDEX Biometrics full coverage across all four card manufacturers in South Korea, representing a production capacity in excess of 100 million smart cards annually, and with world leading metal card manufacturing capabilities.

Cellfie Global has a strong customer base in mainly USA and Europe, markets representing 78% of the 40 million annual metal card shipments. Cellfie Global's leading metal cards provide a unique sensory experience that is driven by card weight, card sound, card technology and a unique design perspective, bringing a different metal card solution to banks and fintechs globally.

"We are excited to provide state-of-the-art biometric capability to our metal card and PVC range of card products enabled by IDEX Biometrics. We see a huge potential for our USA company, ICK International, to accelerate deployment of the next generation of contactless cards and a means for us to differentiate." says Yoo Ki Jong, Chief Executive Officer of Cellfie Global. "Biometric cards are a must have for leading smart card providers like Cellfie" he continues.

"With Cellfie's strong customer portfolio in USA and Europe and a CAGR of metal cards projected at close to 25%, the opportunity for IDEX Biometrics is substantial. As a world leading metal card manufacturer, Cellfie Global strengthens our growing portfolio of smart card makers globally and in South Korea with unique capabilities and an innovative competitive edge", comments Catharina Eklof, Chief Executive Officer of IDEX Biometrics."

Source: Business Research Insights; Metal Card CAGR of 24.4% by 2031

For further information contact:
Marianne Bøe, Head of Investor Relations
E-mail: ir@idexbiometrics.com
Tel: + 47 67 83 91 19

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit www.idexbiometrics.com

About Cellfie Global

??Since 1998 ICK has been a premier supplier of financial cards to all global payment schemes including VISA, Mastercard, American Express, China Union Pay, JCB. As a full-service card manufacturer in all areas of card design, chip deployment and processing, Cellfie/ICK brings leading edge design and products to a global audience. ICK in USA leads metal cards markets and serves customers around the world.

In 2008 ICK launched its financial metal cards products and today enjoys the recognition from the market as one of the leaders in this fast-growing market. ICK has developed leading edge technology to allow for tapping on both sides of the card and holds several patents that enable cardholders to have a great user experience at the point of sales.

For more information, visit www.ickusa.com

Trademark Statement
IDEX, IDEX Biometrics and the IDEX logo are trademarks owned by IDEX Biometrics ASA. All other brands or product names are the property of their respective holders.

About this notice:
This notice was issued by Marianne Bøe, Head of Investor Relations, on 19 November 2024 at 10:15 CET on behalf of IDEX Biometrics ASA.


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.